Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_assertion type Assertion NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_head.
- NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_assertion description "[Furthermore, murine monoclonal antibodies directed against the CD11b/CD18 (CR3) heterodimer have been shown to reduce, by 50%-80%, phagocyte-mediated ischemia-reperfusion injury in several organ systems, such as the myocardium, liver, and gastrointestinal tract and to inhibit development of insulin-dependent diabetes mellitus in nonobese diabetic (NOD) mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_provenance.
- NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_assertion evidence source_evidence_literature NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_provenance.
- NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_assertion SIO_000772 1673028 NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_provenance.
- NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_assertion wasDerivedFrom befree-2016 NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_provenance.
- NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_assertion wasGeneratedBy ECO_0000203 NP551749.RADnUwJVaxe9SMOWm2MkQDc7jPReZcgbCRy_ONMAoKwAk130_provenance.